IRIS
GIORDANO, Paola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.210
EU - Europa 5.828
AS - Asia 1.544
SA - Sud America 19
AF - Africa 5
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 3
Totale 21.614
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.203
DE - Germania 1.364
CN - Cina 1.277
IT - Italia 1.120
SE - Svezia 990
FR - Francia 826
UA - Ucraina 504
FI - Finlandia 355
GB - Regno Unito 329
RU - Federazione Russa 140
SG - Singapore 94
IE - Irlanda 69
IN - India 55
BE - Belgio 48
KR - Corea 42
VN - Vietnam 19
CZ - Repubblica Ceca 13
IR - Iran 13
NL - Olanda 12
BR - Brasile 9
ES - Italia 9
PT - Portogallo 8
AR - Argentina 7
RO - Romania 7
TH - Thailandia 7
IL - Israele 5
PL - Polonia 5
SK - Slovacchia (Repubblica Slovacca) 5
CA - Canada 4
JP - Giappone 4
TR - Turchia 4
AE - Emirati Arabi Uniti 3
BY - Bielorussia 3
CH - Svizzera 3
EU - Europa 3
GE - Georgia 3
GR - Grecia 3
NZ - Nuova Zelanda 3
TW - Taiwan 3
AU - Australia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CL - Cile 2
HK - Hong Kong 2
HR - Croazia 2
MX - Messico 2
MY - Malesia 2
NO - Norvegia 2
PK - Pakistan 2
RS - Serbia 2
UG - Uganda 2
BT - Bhutan 1
CO - Colombia 1
DK - Danimarca 1
GL - Groenlandia 1
HU - Ungheria 1
IQ - Iraq 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
MC - Monaco 1
MM - Myanmar 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
RE - Reunion 1
SA - Arabia Saudita 1
SI - Slovenia 1
SL - Sierra Leone 1
ZA - Sudafrica 1
Totale 21.614
Salva come PNG Salva come JPEG
Città #
Fairfield 1.753
Woodbridge 1.525
Chandler 1.486
Jacksonville 1.265
Houston 928
Ashburn 840
Cambridge 797
Nyköping 761
Seattle 686
Wilmington 592
Ann Arbor 564
Lawrence 392
Roxbury 389
Nanjing 362
Bari 323
Des Moines 244
Beijing 224
New York 190
Boardman 163
Princeton 159
Inglewood 135
San Diego 102
Nanchang 88
Jiaxing 84
Shenyang 80
Hebei 79
Brooklyn 71
Dublin 64
Dearborn 61
Paris 53
Singapore 52
Brussels 47
Los Angeles 47
Tianjin 43
Milan 41
London 40
Changsha 39
Redwood City 39
Rome 34
Helsinki 30
Pune 28
Modugno 23
Guangzhou 22
Padova 22
Shanghai 21
Norwalk 20
Auburn Hills 17
Jinan 16
Dong Ket 15
Napoli 15
Washington 15
Torino 14
Hefei 13
Genoa 12
Prescot 12
Brno 11
Falls Church 11
Ningbo 11
Redmond 11
Hounslow 10
Turin 10
Zhengzhou 10
Ardabil 9
Edinburgh 9
San Severo 9
Wuhan 9
Florence 8
Leawood 8
Palermo 8
San Francisco 8
Simi Valley 8
Augusta 7
Jinhua 7
Naples 7
New Bedfont 7
San Giovanni Rotondo 7
Cutrofiano 6
Genova 6
Grumo Appula 6
Kunming 6
Lisbon 6
Nürnberg 6
Strasbourg 6
São Luís 6
Taizhou 6
Treviso 6
Bologna 5
Boydton 5
Catania 5
Chiswick 5
Fuzhou 5
Indiana 5
Mumbai 5
Ostuni 5
Phoenix 5
Salerno 5
San Mateo 5
Acton 4
Esslingen am Neckar 4
Grafing 4
Totale 15.449
Salva come PNG Salva come JPEG
Nome #
Correzione dell'ipofibrinogenemia acquisita con concentrato di fibrinogeno in bambini affetti da LLA in trattamento con Asparaginasi. L'esperienza di due centri AIEOP 319
Endothelial and Metabolic Function Interactions in Overweight/Obese Children. 201
Combined microRNA and mRNA expression analysis in pediatric multiple sclerosis: an integrated approach to uncover novel pathogenic mechanisms of the disease. 140
Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia 133
Association between miRNAs expression and cognitive performances of Pediatric Multiple Sclerosis patients: A pilot study 132
Association of congenital afibrinogenemia and k-dependent protein C deficiency - a case report 120
Cognitive, emotional, and behavioral profile in children and adolescents with chronic pain associated with rheumatic diseases: A case-control study 119
Lupus anticoagulant, anticardiolipin antibodies and hepatitis C virus infection in thalassaemia 114
Thromboembolic risk in children with nephrotic syndrome 114
Coagulation inhibitors (protein C and antithrombin III) in the preterm infant during the first month of life 113
DETERMINATION OF von WILLEBRAND FACTOR AND FACTOR XIII IN CHILDREN WITH SCHONLEIN HENOCH SYNDROME 112
Von Willebrand factor and factor XIII in children with Henoch-Schonlein purpura 109
Carotenoids and Cardiovascular Risk 107
Vascular Function and Myocardial Performance Indices in Children Born Small for Gestational Age. 107
Porpora trombocitopenica idiopatica (immune) (PTI) acuta in età pediatrica.Linee guida AIEOP per la diagnosi ed il trattamento 107
Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: A scoping review 104
Serum D vitamin levels in children with immune thrombocytopenia 101
Risk factors for subclinical atherosclerosis in diabetic and obese children 100
Creazione del network italiano Asplenia per la gestione coordinata a livello nazionale dei pazienti asplenici: il ruolo dell'AIEOP e di altre società scientifiche 100
Non-alcoholic fatty liver disease is associated with early left ventricular dysfunction in childhood acute lymphoblastic leukaemia survivors. 100
Thrombin generation in children with acute lymphoblastic leukemia (ALL): effects of ALL immunophenotypic subgroup on inherited thrombotic risk factors 99
Uric acid: from a biological advantage to a potential danger. A focus on cardiovascular effects 99
Authors' Reply to "CD10 in the Cytological Diagnosis of Endobronchial Endometriosis" 98
Issues in pediatric haemophilia care 98
Coagulation and fibrinolytic systems in the ill preterm newborn 97
Are all cases of paediatric essential thrombocythaemia really myeloproliferative neoplasms? Analysis of a large cohort 97
Consensus statements on vaccination in patients with haemophilia-Results from the Italian haemophilia and vaccinations (HEVA) project 97
APC resistance in thalassemic patients:an under-lying cause of thrombosis 96
Vaccine administration and the development of immune thrombocytopenic purpura in children 95
Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study. 94
Thromboembolic risk in children with nephrotic syndrome 93
Autoimmune haematological disorders in two Italian children with Kabuki Syndrome 93
B-cell hyperfunction in children with immune thrombocytopenic purpura persists after splenectomy 93
A Narrative Approach to Describe QoL in Children With Chronic ITP 93
Can Anti-Thyroid Antibodies Influence the Outcome of Primary Chronic Immune Thrombocytopenia in Children? 93
APC Resistance in thalassemic patients and under-lying cause of thrombosis 91
New data from the Italian National Register of Congenital Coagulopathies, 2016 Annual Survey 91
A polycentric, randomized, parallel-group, study on Lertal®, a multicomponent nutraceutical, as preventive treatment in children with allergic rhinoconjunctivitis: phase II 91
Chronic immune thrombocytopenia in childhood 90
Impact of sleep respiratory disorders on endothelial function in children. 89
Contemporary deficiency of vitamin K-dependents procoagulants and anticoagulants (PC) in late hemorrhagic disease of newborn 89
Cardiovascular dysfunction and vitamin D status in childhood acute lymphoblastic leukemia survivors 89
Catheter-related infections in pediatric patients with cancer. 88
Organizing national responses for rare blood disorders: the Italian experience with sickle cell disease in childhood. 88
Analysis of Circulating Mediators of Bone Remodeling in Prader-Willi Syndrome 88
Bleeding management in pediatric patients. 88
Pain assessment and management in haemophilia: A survey among Italian patients and specialist physicians 88
Thrombin activation in thalassemia major: effect of iron chelators and splenectomy 87
Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents 86
Idiopathic neutropenia of infancy: Data from the Italian Neutropenia Registry 86
Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies 86
Platelet size for distinguishing between inherited thrombocytopenias and immune thrombocytopenia: a multicentric, real life study 85
Uniparental disomy and pretreatment IGF-1 may predict elevated IGF-1 levels in Prader-Willi patients on GH treatment 85
Coagulation inhibitors (PC and ATIII) in preterm infants during the first month of life 84
null 84
Hereditary hemorrhagic telangiectasia: arteriovenous malformations in children. 84
Resistance to activated protein C in thalassaemic patients: an underlying cause of thrombosis 84
The role of endothelial dysfunction and oxidative stress in cerebrovascular diseases 84
ANKRD26-related thrombocytopenia and myeloid malignancies. 83
Long-term follow-up analysis after rituximab therapy in children with refractory symptomatic ITP: identification of factors predictive of a sustained response 83
Clinical Data of Neonatal Systemic Thrombosis 83
A practical approach to the use of low molecular weight heparins in VTE treatment and prophylaxis in children and newborns. 83
Guidelines for the use of long-term central venous catheter in children with hemato-oncological disorders. On behalf of supportive therapy working group of Italian Association of Pediatric Hematology and Oncology (AIEOP) 82
Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: efficacy and safety of treatment 82
Endothelial dysfunction and cardiovascular risk factors in childhood acute lymphoblastic leukemia survivors Autori 82
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: a communication from the Platelet Physiology SSC 82
Analysis of coagulation and fibrinolysis parameters in obese children and adolescents 81
K-dependent coagulant and anticoagulant factors deficiency in late haemorrhagic disease of the newborn 81
Thromboembolic risk in children with nephrotic syndrom. 80
ITP-QoL Questionnaire for Children with Immune Thrombocytopenia: Italian Version validation's 80
Present and Future of Pediatric Hemophilia Treatment 80
null 80
null 80
HHT in childhood: screening for special patients 79
Effects of deferiprone on immune status and cytokine pattern in thalassaemia major 78
APC resistance in thalassemic patients 78
Unbalanced coagulation-fibrinolysis potential during L-Asparaginase therapy in children with acute lymphoblastic leukaemia 78
Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia 78
Association of interleukin-(IL)10 haplotypes and serum IL-10 levels in the progression of childhood immune thrombocytopenic purpura. 77
Analysis of three genetic polymorphisms as risk factors for thrombosis 77
Protein C deficiency in two children with cerebral thrombosis 77
Mechanisms of enhanced osteoclastogenesis in Alkaptonuria 77
null 77
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial 77
Monoclonal gammopathy of undetermined significance in pediatric kidney transplant: a possible role of Epstein-Barr virus. 76
Splenectomy in children with chronic ITP: Long-term efficacy and relation between its outcome and responses to previous treatments 76
Management of liver disease in thalassemia: main drug targets for a correct therapy 76
La proteina Z e i PIVKA II in età neonatale 75
Successful treatment with Protein C of febrile neutropenia in pediatric patients during cancer therapy 75
Increased mononuclear cell tissue factor and type-2 plasminogen activator inhibitor and reduced plasma fibrinolytic capacity in children with lymphoma 75
null 75
Current management of the hemophilic child: a demanding interlocutor. Quality of life and adequate cost-efficacy analysis. 75
null 75
Effect of oversulfated dermatan sulfate derivatives on platelet aggregation 75
How Physical Activity across the Lifespan Can Reduce the Impact of Bone Ageing: A Literature Review. 75
Management and investigation of neonatal thromboembolic events: Genetic and acquired risk factors 74
Thrombocytopenia-absent-radius syndrome in a child showing a larger 1q21.1 deletion than the one in his healthy mother, and a significant downregulation of the commonly deleted genes. 74
Alterazioni coagulative e fibrinolitiche nel neonato pretermine affetto da: IRDS, asfissia alla nascita, sepsi 74
Neonatal bacterial meningitis: a systematic review of European available data 74
Langerhans cell histiocytosis in a pediatric patient with thrombocytopenia-absent radius syndrome and 1q21.1 deletion: case report and proposal of a rapid molecular diagnosis of 1q21.1 deletion. 74
Totale 9.265
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.776
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.776
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.129 0 290 128 377 492 441 511 393 561 270 507 159
2020/20213.096 329 180 266 223 358 137 282 269 296 381 197 178
2021/20222.854 148 521 46 186 82 106 114 182 152 113 456 748
2022/20233.991 625 379 253 371 507 524 59 422 647 28 95 81
2023/20241.362 116 283 72 148 113 324 40 55 24 37 19 131
2024/2025244 178 66 0 0 0 0 0 0 0 0 0 0
Totale 22.511